Sanofi

HEALTH

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca – CNBC

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca  CNBC Merck Says It Wins US Approval…

Read More »
BUSINESS

Sanofi to buy US biopharma group Blueprint for up to $9.5 billion

By Dominique Patton and Geert De Clercq PARIS (Reuters) -France’s Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for…

Read More »
Back to top button